Coffee May Reduce Risk of Liver Cancer

Coffee May Reduce Risk of Liver Cancer (Reuters)

Habitual coffee drinking seems to be associated with a lower risk of developing liver cancer, according to a study conducted in Japan and reported in the Journal of the National Cancer Institute. A second study in the same journal suggests that caffeinated coffee consumption is not tied to colorectal cancer, although decaffeinated coffee may decrease the risk of rectal cancer.

Dr. Manami Inoue and colleagues at the National Cancer Center in Tokyo surveyed approximately 90,000 individuals in 1990 or between 1993 and 1994. The subjects were followed through the end of 2001, during which time 334 were diagnosed with liver cancer. The risk of liver cancer among those who almost never drank coffee was twice as high as for those who drank coffee on a daily basis. The investigators observed no association between green tea intake and the risk of liver cancer, suggesting that antioxidants unique to coffee may be responsible for its protective effects.

In the second article, Dr. Karin B. Michels at Brigham and Women’s Hospital in Boston and colleagues analyzed data from 88,000 women in the Nurses’ Health Study, which began in 1976, and from 46,000 men in the Health Professionals’ Follow-up Study, which began in 1986. During followup through 1998, there were 1433 cases of colorectal cancer. Total coffee or tea consumption was not associated with the development of colorectal cancer in either group. However, among subjects who reported never drinking decaffeinated coffee, the occurrence of rectal cancer was 58% higher than among those who drank two or more cups per day.

This is encouraging news for those of us who drink copious amounts of coffee.

One wonders about the survey methodology, however. Is this simply a univariate analysis or does it control for the fact that the types of people who drink coffee versus those who never drink coffee might be otherwise different? For example, we know academics are notorious coffee hounds.

Please follow and like us:
FILED UNDER: Health,
James Joyner
About James Joyner
James Joyner is Professor and Department Head of Security Studies at Marine Corps University's Command and Staff College and a nonresident senior fellow at the Scowcroft Center for Strategy and Security at the Atlantic Council. He's a former Army officer and Desert Storm vet. Views expressed here are his own. Follow James on Twitter @DrJJoyner.

Comments

  1. Jared says:

    I guess the real question then becomes whether I’ve offset the help to my liver that comes from drinking copious amounts of coffee by drinking copious amounts of alcohol…sadly I think we all know the answer to that.

  2. caltechgirl says:

    yes, but being an academic has little to do with whether or not you’ll end up with liver cancer. It’s probably assumed that coffee drinking is more common in the “general population” than liver cancer, so that wouldn’t matter.

  3. Bob says:

    I didn’t check carefully, but is this a study of PRIMARY hepatoma or secondary? It makes a big difference. Primary is rather uncommon in the Western world, but more common in the Oriental. Secondary is very common, sadly, as it follows from the presence of from other cancers already well developed in the body.